Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Jerome who wrote (5873)	6/8/2018 10:40:28 AM
From: Kirk ©	Read Replies (1) \| Respond to of 26909

Thanks for the kind words The awards for you and your newsletter attest to that. Timer Digest (I shared their Timer of the Year Award for 2017) wants to feature me on the cover later this month so I have to spend some time updating their article.... probably not spend any more time here until I get that done! I barbell risk. Take some high risk with a part of your portfolio and then with the majority keep it in index funds so you can compare your results to the index funds. You seem to forget that much of Europe and much of the US still believes owning stocks is high risk behavior. The specific stocks I'm using are in the newsletter with target prices to buy and sell... I just took profits on one yesterday after a nice (19%) gain on some of the shares I added to the position on 4/3/18... I do the trading in IRAs for my own money where you defer taxes and the results can compound. Now and then I'll harvest some really long term gains in my taxable accounts just to take advantage of the low cap gains taxes, etc. For the super high risk, I had two small biotechs. One has done well for us (and now sits just below where I bought back shares sold much higher) and one I got out of for a loss so maybe I'd have done better trading around a core position in a biotech ETF. I've traded a managed biotech fund in my IRA since there is no charge to buy and sell. I'm many times on house money with that so I did better than the two small stocks in the newsletter... I think the reason for that is small biotech stocks not making money are way out of favor these days while the big ones in the funds are doing well, probably similar to the NASDAQ soaring with money into a few stocks but not all stocks like MU or FNSR. So, if you want a lot of risk for high reward, look to buy what is currently out of favor and hope it rotates back into favor before the next bear market.